Terray Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
144
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$25M
- Investors
-
22
Terray Therapeutics General Information
Description
Developer of a drug discovery platform designed to accelerate the development of small-molecule therapeutics. The company's platform integrates ultra-dense microarray technology, generative artificial intelligence, automated laboratory experimentation, chemistry foundation modeling, and potency prediction, enabling biotechnology companies to efficiently explore molecular spaces and optimize drug design through iterative cycles of virtual experimentation and data generation.
Contact Information
Website
www.terraytx.aiCorporate Office
- 750 Royal Oaks Drive
- Suite 100
- Monrovia, CA 91016
- United States
Corporate Office
- 750 Royal Oaks Drive
- Suite 100
- Monrovia, CA 91016
- United States
Terray Therapeutics Timeline
Terray Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Debt - General | 01-Apr-2025 | $25M | Completed | Pre-Clinical Trials | ||
| 6. Later Stage VC (Series B) | 17-Oct-2024 | Completed | Pre-Clinical Trials | |||
| 5. Early Stage VC (Series A) | 15-Feb-2022 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 30-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 13-Mar-2019 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 01-Oct-2018 | $1.3M | $1.3M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Terray Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A | ||||||||
| Seed-2 | ||||||||
| Seed-1 | 1,771,776 | $0.000010 | 6% | $0.78 | $0.78 | 1x | $0.78 | 3.35% |
| Seed | 5,107,771 | $0.000010 | 6% | $0.98 | $0.98 | 1x | $0.98 | 9.67% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Terray Therapeutics Comparisons
Industry
Financing
Details
Terray Therapeutics Competitors (20)
One of Terray Therapeutics’s 20 competitors is Generate Biomedicines, a Formerly VC-backed company based in Somerville, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Generate Biomedicines | Formerly VC-backed | Somerville, MA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| BPS Bioscience | Corporation | San Diego, CA | ||||
| Lisata Therapeutics | Corporation | Basking Ridge, NJ | ||||
| Genesis Molecular AI | Venture Capital-Backed | San Mateo, CA |
Terray Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Terray Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Terray Therapeutics Investors (22)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Apandion | Asset Manager | Minority | ||
| Angel (individual) | Minority | |||
| Bedford Ridge Capital | PE/Buyout | Minority | ||
| Angel (individual) | Minority | |||
| Mana Ventures | Venture Capital | Minority |
Terray Therapeutics FAQs
-
When was Terray Therapeutics founded?
Terray Therapeutics was founded in 2018.
-
Where is Terray Therapeutics headquartered?
Terray Therapeutics is headquartered in Monrovia, CA.
-
What is the size of Terray Therapeutics?
Terray Therapeutics has 144 total employees.
-
What industry is Terray Therapeutics in?
Terray Therapeutics’s primary industry is Drug Discovery.
-
Is Terray Therapeutics a private or public company?
Terray Therapeutics is a Private company.
-
What is Terray Therapeutics’s current revenue?
The current revenue for Terray Therapeutics is .
-
How much funding has Terray Therapeutics raised over time?
Terray Therapeutics has raised $226M.
-
Who are Terray Therapeutics’s investors?
Apandion, , Bedford Ridge Capital, , and Mana Ventures are 5 of 22 investors who have invested in Terray Therapeutics.
-
Who are Terray Therapeutics’s competitors?
Generate Biomedicines, Exscientia, BPS Bioscience, Lisata Therapeutics, and Genesis Molecular AI are some of the 20 competitors of Terray Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
